{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:46:09Z","timestamp":1793245569353,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018889","name":"Multiple System Atrophy Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ard.2025.06.2133","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:22:37Z","timestamp":1752621757000},"page":"1900-1908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["AYLo study\u2013elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-1143","authenticated-orcid":false,"given":"Simon M.","family":"Petzinna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8963-2922","authenticated-orcid":false,"given":"Sophie-Marie","family":"Kirch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-9516","authenticated-orcid":false,"given":"Maike S.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-6550","authenticated-orcid":false,"given":"Claus-J\u00fcrgen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3810-2229","authenticated-orcid":false,"given":"Lena","family":"Kreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Gheitasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Karakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayk","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2084-8463","authenticated-orcid":false,"given":"Raul N.","family":"Jamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin S.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ard.2025.06.2133_bib0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41431-019-0533-z","article-title":"Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals","volume":"28","author":"Danielsson","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41588-018-0267-9","article-title":"Mosaic loss of chromosome Y in leukocytes matters","volume":"51","author":"Forsberg","year":"2019","journal-title":"Nat Genet"},{"issue":"7784","key":"10.1016\/j.ard.2025.06.2133_bib0003","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","article-title":"Genetic predisposition to mosaic Y chromosome loss in blood","volume":"575","author":"Thompson","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2133_bib0004","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng.2966","article-title":"Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer","volume":"46","author":"Forsberg","year":"2014","journal-title":"Nat Genet"},{"issue":"6217","key":"10.1016\/j.ard.2025.06.2133_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.1262092","article-title":"Mutagenesis. Smoking is associated with mosaic loss of chromosome Y","volume":"347","author":"Dumanski","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ard.2025.06.2133_bib0006","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ng.3545","article-title":"Mosaic loss of chromosome Y is associated with common variation near TCL1A","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2133_bib0007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0008","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41467-018-02858-0","article-title":"Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential","volume":"9","author":"Wong","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2133_bib0009","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ajhg.2016.05.014","article-title":"Mosaic loss of chromosome Y in blood is associated with Alzheimer disease","volume":"98","author":"Dumanski","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.ard.2025.06.2133_bib0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ng.3821","article-title":"Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility","volume":"49","author":"Wright","year":"2017","journal-title":"Nat Genet"},{"issue":"6603","key":"10.1016\/j.ard.2025.06.2133_bib0011","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.abn3100","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ard.2025.06.2133_bib0012","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/STROKEAHA.123.043551","article-title":"Mosaic loss of chromosome Y is associated with functional outcome after ischemic stroke","volume":"54","author":"Dorvall","year":"2023","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.ard.2025.06.2133_bib0013","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.124.069139","article-title":"Loss of Y chromosome and cardiovascular events in chronic kidney disease","volume":"150","author":"Weyrich","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0014","article-title":"Predictors of mosaic chromosome Y loss and associations with mortality in the UK","volume":"8","author":"Loftfield","year":"2018","journal-title":"Biobank. Sci Rep."},{"issue":"3","key":"10.1016\/j.ard.2025.06.2133_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s44161-024-00441-z","article-title":"Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure","volume":"3","author":"Horitani","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.ard.2025.06.2133_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/srep44876","article-title":"Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma","volume":"7","author":"Arseneault","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0017","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1038\/s41598-024-60049-y","article-title":"Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases","volume":"14","author":"W\u00f3jcik","year":"2024","journal-title":"Sci Rep"},{"issue":"27","key":"10.1016\/j.ard.2025.06.2133_bib0018","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2133_bib0019","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ard.2025.06.2133_bib0020","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/rheumatology\/keae550","article-title":"Vasculitis associated with VEXAS syndrome","volume":"64","author":"Sullivan","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2133_bib0021","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/RLU.0000000000004506","article-title":"Aortitis PET imaging in VEXAS syndrome: a case report","volume":"48","author":"Grambow-Velilla","year":"2023","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.ard.2025.06.2133_bib0022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"22","key":"10.1016\/j.ard.2025.06.2133_bib0023","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2133_bib0024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2133_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103328","article-title":"The role of autoimmunity and autoinflammation in giant cell arteritis: a systematic literature review","volume":"22","author":"Sch\u00e4fer","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ard.2025.06.2133_bib0026","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2018.00809","article-title":"Expression and function of IL12\/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: contribution of p40 to Th1- and Th17-mediated inflammatory pathways","volume":"9","author":"Esp\u00edgol-Frigol\u00e9","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ard.2025.06.2133_bib0027","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2133_bib0028","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"399","key":"10.1016\/j.ard.2025.06.2133_bib0029","doi-asserted-by":"crossref","first-page":"eaal3322","DOI":"10.1126\/scitranslmed.aal3322","article-title":"The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-notch pathway","volume":"9","author":"Wen","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ard.2025.06.2133_bib0030","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3389\/fimmu.2019.01638","article-title":"Decreased expression of negative immune checkpoint VISTA by CD4+ T cells facilitates T helper 1, T helper 17, and T follicular helper lineage differentiation in GCA","volume":"10","author":"Hid Cadena","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ard.2025.06.2133_bib0031","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2133_bib0032","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10067-018-4240-x","article-title":"Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-na\u00efve patients","volume":"38","author":"Burja","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2133_bib0033","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/acr.20043","article-title":"Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis","volume":"62","author":"Garc\u00eda-Mart\u00ednez","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10031","key":"10.1016\/j.ard.2025.06.2133_bib0034","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ard.2025.06.2133_bib0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.06.2133_bib0036","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2133_bib0037","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.06.2133_bib0038","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ard.2025.01.018","article-title":"The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study","volume":"84","author":"Monti","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105494","article-title":"Epidemiology and predictors of relapse in giant cell arteritis: a systematic review and meta-analysis","volume":"90","author":"Moreel","year":"2023","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2133_bib0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3324\/haematol.2019.240689","article-title":"Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells","volume":"106","author":"Ouseph","year":"2021","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.ard.2025.06.2133_bib0041","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/hmg\/ddad133","article-title":"Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations","volume":"32","author":"Hubbard","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0042","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13578-023-01075-7","article-title":"Circulating macrophages as the mechanistic link between mosaic loss of Y-chromosome and cardiac disease","volume":"13","author":"Xu","year":"2023","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0043","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12864-024-10168-7","article-title":"Loss of chromosome Y in regulatory T cells","volume":"25","author":"Mattisson","year":"2024","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.ard.2025.06.2133_bib0044","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1038\/s41598-020-63042-3","article-title":"Immunomodulatory role of interleukin-33 in large vessel vasculitis","volume":"10","author":"Desbois","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ard.2025.06.2133_bib0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fimmu.2020.00735","article-title":"CD28 signaling drives notch ligand expression on CD4 T cells","volume":"11","author":"Mitra","year":"2020","journal-title":"Front Immunol"},{"issue":"26","key":"10.1016\/j.ard.2025.06.2133_bib0046","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ard.2025.06.2133_bib0047","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2133_bib0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2133_bib0049","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2133_bib0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ard.2025.06.2133_bib0051","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"6568","key":"10.1016\/j.ard.2025.06.2133_bib0052","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.aba9304","article-title":"Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis","volume":"374","author":"Avagyan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ard.2025.06.2133_bib0053","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/art.42738","article-title":"Association of somatic TET2 mutations with giant cell arteritis","volume":"76","author":"Robinette","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.06.2133_bib0054","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard-2023-224933","article-title":"Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu\u2019s arteritis, ANCA-associated vasculitis and giant cell arteritis","volume":"83","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:13:43Z","timestamp":1779855223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725041883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0003496725041883"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2133","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AYLo study\u2013elevated relapse risk and dysregulated proinflammatory signalling in giant cell arteritis patients with mosaic loss of the Y chromosome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}